Results 51 to 60 of about 2,360,733 (398)

Percutaneous microwave ablation of disappearing colorectal liver metastases using US-MR fusion imaging guidance with integration of pre-chemotherapy imaging: A case report

Current Problems in Cancer: Case Reports, 2022
Liver metastases that disappear after chemotherapy are called vanishing or disappearing liver metastases. These metastases represent a diagnostic and clinical challenge as their biological behaviour is hardly predictable and their treatment is not ...
Arianna Nivolli, Emanuele Barabino, Francesca Lacelli, Matteo Arnò, Diego Ivald, Giulia Pittaluga, Andrea Percivale, Paolo Gazzo   +7 more
doaj   +1 more source

Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases

, 2008
The purpose of this study was to evaluate the feasibility of a totalliver- volume perfusion CT (CTP) technique for the detection and characterization of livermetastases.
Cornelis van Kuijk, van Waesberghe, Jan, Meijer, Sybren, Weide, Lineke van der, Sybren Meijer, van Kuijk, C., van den Tol, Petrousjka, Lineke van der Weide, van den Tol, M.P., van der Weide, L., Meijer, S., van der Weide, Lineke, Meijerink, Martijn, Martijn R. Meijerink, Jan Hein T. M. van Waesberghe, Meijerink, M.R., van Waesberghe, J.H.T.M., Kuijk, Cornelis van, Petrousjka van den Tol, Waesberghe, Jan van, Tol, Petrousjka van den   +20 more
core   +1 more source

Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

Journal of the National Cancer Institute, 2017
Background: Tumor ablation is often employed for unresectable colorectal liver metastases. However, no survival benefit has ever been demonstrated in prospective randomized studies.
T. Ruers, F. van Coevorden, C. Punt, J. Pierie, I. Borel-Rinkes, J. Ledermann, G. Poston, W. Bechstein, M. Lentz, M. Mauer, G. Folprecht, E. Van Cutsem, M. Ducreux, B. Nordlinger   +13 more
semanticscholar   +1 more source

First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI)

, 2012
The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic ...
Hammerstingl, Renate Maria, Mack, Martin G., Gallus, Christof, Eichler, Katrin, Gruber-Rouh, Tatjana, Vogl, Thomas J., Zangos, Stephan   +6 more
core   +1 more source

The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation

, 2014
Background: Many deaths from cancer are caused by metastatic burden. Prognosis and survival rates vary, but survival beyond 5 years of patients with untreated metastatic disease in the liver is rare.
Breen, D., George, S., Joanna Picot, Steve George, Colquitt, Jillian, Mendes, Diana, Emma Loveman, Primrose, John, Clegg, Andrew J., Picot, J., John Primrose, Cunningham, David, Andrew J Clegg, Ruters, Theo, Theo Ruers, Colquitt, J.L., Cunningham, D., Moore, E., Ruers, T., Jones, Jeremy, Jeremy Jones, Picot, Joanna, Breen, David J., Jillian L Colquitt, Primrose, J.N., Clegg, Andrew, Graeme Poston, Loveman, Emma, Emily Moore, Moore, Emily, Diana Mendes, David J Breen, Poston, G., Poston, Graeme, George, Steve, David Cunningham   +35 more
core   +1 more source

Whole-volume vs. segmental CT texture analysis of the liver to assess metachronous colorectal liver metastases [PDF]

, 2017
Purpose: It is unclear whether changes in liver texture in patients with colorectal cancer are caused by diffuse (e.g., perfusional) changes throughout the liver or rather based on focal changes (e.g., presence of occult metastases).
D. M. J. Lambregts, R. C. J. Beckers, M. Maas, Houwers, J. B., Dejong, C. H., R. G. H. Beets-Tan, G. L. Beets, C. H. Dejong, J. B. Houwers, Lambregts, D. M. J., L. A. da Costa Andrade, Beets, G. L., R. S. Schnerr, da Costa Andrade, L. A., Beets-Tan, R. G. H., Maas, M., Beckers, R. C. J., Schnerr, R. S.   +17 more
core   +1 more source

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

Annals of Oncology, 2018
Background Long-term data with immune checkpoint inhibitors in non-small-cell lung cancer (NSCLC) are limited. Two phase III trials demonstrated improved overall survival (OS) and a favorable safety profile with the anti-programmed death-1 antibody ...
E. Vokes, N. Ready, E. Felip, L. Horn, M. Burgio, S. Antonia, O. A. Frontera, S. Gettinger, E. Holgado, D. Spigel, D. Waterhouse, M. Dómine, M. Garassino, L. Chow, G. Blumenschein, F. Barlesi, B. Coudert, J. Gainor, O. Arrieta, J. Brahmer, C. Butts, M. Steins, W. Geese, Ang Li, D. Healey, L. Crinò   +25 more
semanticscholar   +1 more source

Risk factors for residual liver recurrence of colorectal cancer after resection of liver metastases and significance of adjuvant chemotherapy

Asian Journal of Surgery
Objective: The risk factors for residual liver recurrence after resection of colorectal cancer liver metastases were analyzed separately for synchronous and metachronous metastases.
Hiroko Sawano, Hiroshi Matsuoka, Tomohiro Mizuno, Tadahiro Kamiya, Yongchol Chong, Hideaki Iwama, Takeshi Takahara, Junichiro Hiro, Koki Otsuka, Takuma Ishihara, Takahiro Hayashi, Kouichi Suda   +11 more
doaj   +1 more source

Liver metastases from lung cancer

, 2014
With the improvement of techniques in liver surgery, indications to hepatic resections have been extended in the last decades to liver metastases secondary to non-colorectal, non-neuroendocrine tumors.
PINNA, ANTONIO DANIELE, RAVAIOLI, MATTEO, Flavia Neri, Antonio Daniele Pinna, Matteo Cescon, Giorgio Ercolani, Matteo Ravaioli, CESCON, MATTEO, ERCOLANI, GIORGIO, NERI, FLAVIA   +9 more
core   +1 more source

Multidisciplinary approach of liver metastases from colorectal cancer

Annals of Gastroenterological Surgery, 2019
Colorectal cancer liver metastases (CRLM) represent most of the causes of death in patients with colorectal cancer. Surgical resection is the only treatment that can provide the possibility of prolonged survival, or even cure, for patients with CRLM ...
R. Adam, Y. Kitano
semanticscholar   +1 more source